Drug Profile
ZM 181037
Alternative Names: ICI 181037Latest Information Update: 06 Sep 2000
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Antiarrhythmics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias; Heart failure; Hypertension
Most Recent Events
- 06 Sep 2000 Discontinued-Preclinical for Arrhythmias in United Kingdom (IV)
- 06 Sep 2000 Discontinued-Preclinical for Arrhythmias in United Kingdom (PO)
- 06 Sep 2000 Discontinued-Preclinical for Heart failure in United Kingdom (IV)